Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 7, 2015, Pages 729-734

  Nobile Orazio, Eduardo ^a   Cocito, Dario ^b   Jann, Stefano ^c   Uncini, Antonino ^d   Messina, Paolo ^e   Antonini, Giovanni ^f   Fazio, Raffaella ^g   Gallia, Francesca ^a   Schenone, Angelo ^h   Francia, Ada ⁱ   Pareyson, Davide ^j   Santoro, Lucio ^k   Tamburin, Stefano ^l   Cavaletti, Guido ^m   Giannini, Fabio ⁿ   Sabatelli, Mario ^o   Beghi, Ettore ^e   Paolasso, Ilaria ^b   De Toni Franceschini, Luisa ^o   Notturno, Francesca ^d   Clemenzi, Alessandro ^f   Bianchi, Francesca ^g   Fiorina, Elisabetta ^h   Pontecorvo, Simona ⁱ   Piscosquito, Giuseppe ^j   Manganelli, Fiore ^k   Praitano, Maria Luigia ^l   Piatti, Marialuisa ^m   Torzini, Antonio ⁿ   Luigetti, Marco ^o   Macchia, Roberta ^p   more..

^a UNIVERSITY OF MILAN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ POLICLINICO UMBERTO I   (Italy)

^j DEPARTMENT OF NEUROSURGERY   (Italy)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l UNIVERSITY OF VERONA   (Italy)

^m UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁿ UNIVERSITY OF SIENA   (Italy)

^o CATHOLIC UNIVERSITY   (Italy)

^p Kedrion SpA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; PLACEBO; ANTIINFLAMMATORY AGENT; IMMUNOLOGIC FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG FATALITY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FOLLOW UP; GENERAL CONDITION DETERIORATION; HEART ARREST; HUMAN; HYPERTENSION; NEUROPATHY; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RELAPSE; RESPIRATORY FAILURE; TREATMENT DURATION; TREATMENT WITHDRAWAL; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; METHYLPREDNISOLONE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84939251115     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307515     Document Type: Article

References (27)

1. Hahn AF, Hartung H-P, Dyck PJ. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK. eds. Peripheral neuropathy. 4th edn. Philadelphia: Elsevier Saunders, 2005: 2221-53.
2. Vallat J-M, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010; 9: 402-12.
3. Hughes RAC, Allen D, Makowska A, et al. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2006; 11: 30-46.
4. Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2009; (1): CD001797.
5. Mehndiratta MM, Hughes RAC Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002; (1): CD002062.
6. Mehndiratta MM, Hughes RAC, Agarwal P. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2004; (3): CD003906.
7. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005; 10: 220-8.
8. Hughes RAC, Bensa S, Willison HJ, et al. and the Inflammatory Neuropathy Cause and Treatment (INCAT) group randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 195-201.
9. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994; 36: 838-45.
10. Nobile-Orazio E, Cocito D, Jann S, et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol 2012; 11: 493-502.
11. Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomized placebo-controlled trial. Lancet Neurol 2008; 7: 136-44.
12. Hughes RAC, Gorson KC, Cros D, et al. Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2010; 74: 651-7.
13. Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed high-dose dexamethasone or short term prednisolone treatment. Neurology 2012; 78: 1079-84.
14. van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind randomised controlled trial. Lancet Neurol 2010; 9: 245-53.
15. Graham RC, Hughes RA. A modified peripheral neuropathy scale: the overall neuropathy limitation scale. J Neurol Neurosurg Psychiatry 2006; 77: 973-6.
16. Bamford JM, Sandercock PA, Warlow CP, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; 20: 828.
17. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14: 1103-9.
18. Kuwabara S, Misawa S, Mori M, et al. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a 5 year follow-up of 38 cases. J Neurol Neurosurg Psychiatry 2006; 77: 66-70.
19. Rabin M, Mutlu G, Stojkovic T, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal. J Neurol Neurosurg Psychiatry 2014; 85: 901-6.
20. Dukes MN Meyler's side effects of drugs. New York: Elsevier, 1996: 1193-209.
21. Mahdi-Rogers M, Swan AV, van Doorn PA, et al. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2010; 11: CD003280.
22. Dyck PJ, O'Brien P, Swanson C, et al. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology 1995; 35: 1173-6.
23. Hadden RDM, Sharrack B, Bensa S, et al. Randomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1999; 53: 57-61.
24. RMC Trial Group. Pilot Randomised Controlled Trial of Methotrexate for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (RMC Trial). Lancet Neurol 2009; 8: 158-64.
25. Muley SA, Kelkar P, Parr GJ. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol 2008; 65: 1460-4.
26. Lopate G, Pestronk A, Al-Lozi M. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Arch Neurol 2005; 62: 249-54.
27. Molenaar DSM, van Doorn PA, Vermeulen M. Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1997; 62: 388-90.